Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Norfolk, VA
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated:  11/28/2012
Stanford University
mi
from
Stanford, CA
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated: 11/28/2012
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated:  11/28/2012
Barbara Davis Center for Childhood Diabetes
mi
from
Denver, CO
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated: 11/28/2012
Barbara Davis Center for Childhood Diabetes
mi
from
Denver, CO
Click here to add this to my saved trials
Sleep Intervention for Youth With Type 1 Diabetes
Students With Diabetes: Does Optimizing Sleep Promote Classroom, Behavioral, and Disease-Related Improvement
Status: Enrolling
Updated:  11/29/2012
Angel Wing Clinic for Diabetes
mi
from
Tucson, AZ
Sleep Intervention for Youth With Type 1 Diabetes
Students With Diabetes: Does Optimizing Sleep Promote Classroom, Behavioral, and Disease-Related Improvement
Status: Enrolling
Updated: 11/29/2012
Angel Wing Clinic for Diabetes
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Indianapolis, IN
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Erlanger, KY
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Erlanger, KY
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Baton Rouge, LA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Hyattsville, MD
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Hyattsville, MD
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
North Dartmouth, MA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Omaha, NE
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Omaha, NE
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Lebanon, NH
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Philadelphia, PA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Charleston, SC
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Charleston, SC
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Memphis, TN
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Memphis, TN
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Salt Lake City, UT
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Arlington, VA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Arlington, VA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Spokane, WA
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Spokane, WA
Click here to add this to my saved trials
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Martinsburg, WV
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/30/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Martinsburg, WV
Click here to add this to my saved trials
Sitagliptin in Type I Diabetic Patients
Effect of Sitagliptin on Glycemic Control, Post-prandial Glucagon, and Inflammation in Type 1 Diabetics
Status: Enrolling
Updated:  11/30/2012
115 Flint Road
mi
from
Williamsville, NY
Sitagliptin in Type I Diabetic Patients
Effect of Sitagliptin on Glycemic Control, Post-prandial Glucagon, and Inflammation in Type 1 Diabetics
Status: Enrolling
Updated: 11/30/2012
115 Flint Road
mi
from
Williamsville, NY
Click here to add this to my saved trials
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
An Evaluation and Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References
Status: Enrolling
Updated:  12/6/2012
Accelovance, Inc.
mi
from
San Diego, CA
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
An Evaluation and Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References
Status: Enrolling
Updated: 12/6/2012
Accelovance, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Exercise Dose-Response Effects in Prediabetes
Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms
Status: Enrolling
Updated:  12/10/2012
Duke Center For Living
mi
from
Durham, NC
Exercise Dose-Response Effects in Prediabetes
Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms
Status: Enrolling
Updated: 12/10/2012
Duke Center For Living
mi
from
Durham, NC
Click here to add this to my saved trials
Intervention to Increase Screening for Glucocorticoid Induced Diabetes
Intervention to Increase Screening for Glucocorticoid Induced Diabetes
Status: Enrolling
Updated:  12/13/2012
Liron Caplan
mi
from
Aurora, CO
Intervention to Increase Screening for Glucocorticoid Induced Diabetes
Intervention to Increase Screening for Glucocorticoid Induced Diabetes
Status: Enrolling
Updated: 12/13/2012
Liron Caplan
mi
from
Aurora, CO
Click here to add this to my saved trials
Screening for Prediabetes
Screening for Prediabetes and Early Diabetes in Primary Care
Status: Enrolling
Updated:  12/17/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Screening for Prediabetes
Screening for Prediabetes and Early Diabetes in Primary Care
Status: Enrolling
Updated: 12/17/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
A Multi Center, Randomized , Double Blind, Placebo-controlled, Study of the Safety, Tolerability, and Effects on Arterial Structure and Function of ACZ885 in Patients With Clinically Evident Atherosclerosis and Either T2DM or IGT
Status: Enrolling
Updated:  12/18/2012
Novartis Investigative Site
mi
from
Mineola, NY
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
A Multi Center, Randomized , Double Blind, Placebo-controlled, Study of the Safety, Tolerability, and Effects on Arterial Structure and Function of ACZ885 in Patients With Clinically Evident Atherosclerosis and Either T2DM or IGT
Status: Enrolling
Updated: 12/18/2012
Novartis Investigative Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
A Multi Center, Randomized , Double Blind, Placebo-controlled, Study of the Safety, Tolerability, and Effects on Arterial Structure and Function of ACZ885 in Patients With Clinically Evident Atherosclerosis and Either T2DM or IGT
Status: Enrolling
Updated:  12/18/2012
Novartis Investigative Site
mi
from
Cincinatti, OH
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
A Multi Center, Randomized , Double Blind, Placebo-controlled, Study of the Safety, Tolerability, and Effects on Arterial Structure and Function of ACZ885 in Patients With Clinically Evident Atherosclerosis and Either T2DM or IGT
Status: Enrolling
Updated: 12/18/2012
Novartis Investigative Site
mi
from
Cincinatti, OH
Click here to add this to my saved trials
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
A Phase 1, Double-blind, Randomized, 2-Way Crossover, Placebo-controlled Study to Investigate the Effect of AMG 151 on 24-hour Ambulatory Blood Pressure and Glucose Levels in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/19/2012
Clinical Research Facility
mi
from
San Diego, CA
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
A Phase 1, Double-blind, Randomized, 2-Way Crossover, Placebo-controlled Study to Investigate the Effect of AMG 151 on 24-hour Ambulatory Blood Pressure and Glucose Levels in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/19/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Roux-en-Y-Gastric Bypass vs. Lifestyle Modification and Medical Therapy in the Treatment of Type 2 Diabetes
Roux-en-Y-Gastric Bypass (RYGB) Versus Lifestyle Modification Plus Medical Therapy in the Treatment of Type 2 Diabetes in Overweight-to-Moderately Obese Patients: A Randomized Clinical Trial
Status: Enrolling
Updated:  12/20/2012
Weill-Cornell Medical College
mi
from
New York, NY
Roux-en-Y-Gastric Bypass vs. Lifestyle Modification and Medical Therapy in the Treatment of Type 2 Diabetes
Roux-en-Y-Gastric Bypass (RYGB) Versus Lifestyle Modification Plus Medical Therapy in the Treatment of Type 2 Diabetes in Overweight-to-Moderately Obese Patients: A Randomized Clinical Trial
Status: Enrolling
Updated: 12/20/2012
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Honolulu, HI
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Boston, MA
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Asheville, NC
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Akron, OH
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Anderson, SC
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Bristol, TN
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Houston, TX
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Burke, VA
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  12/20/2012
Pfizer Investigational Site
mi
from
Madison, WI
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety And Efficacy Of PF-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 12/20/2012
Pfizer Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients With Type 2 Diabetes Mellitus Managed With Oral Hypoglycemic Agent(s)
Status: Enrolling
Updated:  1/4/2013
Arena Pharmaceuticals, Inc.
mi
from
San Diego, CA
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients With Type 2 Diabetes Mellitus Managed With Oral Hypoglycemic Agent(s)
Status: Enrolling
Updated: 1/4/2013
Arena Pharmaceuticals, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
A Randomized, Double-blind, Placebo-controlled, 4-part, Interwoven Single- and Multiple-ascending Dose Study to Assess Safety, Tolerability, PK and PD of LIK066 in Healthy Subjects and in Patients With T2DM
Status: Enrolling
Updated:  1/11/2013
Novartis Investigative Site
mi
from
Miami, FL
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
A Randomized, Double-blind, Placebo-controlled, 4-part, Interwoven Single- and Multiple-ascending Dose Study to Assess Safety, Tolerability, PK and PD of LIK066 in Healthy Subjects and in Patients With T2DM
Status: Enrolling
Updated: 1/11/2013
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
A Randomized, Double-blind, Placebo-controlled, 4-part, Interwoven Single- and Multiple-ascending Dose Study to Assess Safety, Tolerability, PK and PD of LIK066 in Healthy Subjects and in Patients With T2DM
Status: Enrolling
Updated:  1/11/2013
Novartis Investigative Site
mi
from
Omaha, NE
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
A Randomized, Double-blind, Placebo-controlled, 4-part, Interwoven Single- and Multiple-ascending Dose Study to Assess Safety, Tolerability, PK and PD of LIK066 in Healthy Subjects and in Patients With T2DM
Status: Enrolling
Updated: 1/11/2013
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema.
Status: Enrolling
Updated:  1/13/2013
Retina Macula Institute
mi
from
Torrance, CA
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema.
Status: Enrolling
Updated: 1/13/2013
Retina Macula Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Vitamin D and Adipose Tissue Inflammation
Vitamin D and Adipose Tissue Inflammation
Status: Enrolling
Updated:  1/15/2013
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Vitamin D and Adipose Tissue Inflammation
Vitamin D and Adipose Tissue Inflammation
Status: Enrolling
Updated: 1/15/2013
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated:  1/16/2013
St. Elizabeth's Medica Center
mi
from
Brighton, MA
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
St. Elizabeth's Medica Center
mi
from
Brighton, MA
Click here to add this to my saved trials